The Absorb GT1 Bioresorbable Vascular Scaffold (BVS) is a temporary scaffold that will fully resorb over time and is indicated for improving coronary luminal diameter in patients with ischemic heart disease due to de novo native coronary artery lesions (length ≤ 24 mm) with a reference vessel diameter of ≥ 2.5 mm and ≤ 3.75 mm
What are the Potential Risk and Complications?
Treatment options for CAD have become increasingly common but, as with any invasive procedure, there are potential risk factors and complications. Serious complications do not occur often, and research is ongoing to make these procedures even safer and more effective.
The risk of complications from percutaneous treatment methods may be higher for individuals:
Listed below are known potential risks that may occur to you during or after placement of the Absorb GT1 BVS. These risks are not specific to the Absorb GT1 BVS device and may occur with any similar coronary artery stent:
©2017 Abbott. All rights reserved. Please read the Legal Notice for further details.
All drawings are artist's representations only and should not be considered as engineering drawings or photographs.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.